Program
The program has been meticulously designed to serve as a platform for sharing the latest breakthroughs and insights in hematology. It encompasses a variety of engaging sessions that delve into the most advanced areas in hematological sciences, promising a rich and enlightening experience.
We invite you to join us on this journey of exploration and discovery, as we collectively strive to enhance our understanding and treatment of hematology conditions.
Session Highlights
Keynote Lecture:
AI in Hematology
Session I:
Pediatric Hematology- I
Session Covers the AML/MDS in Down Syndrome, Establishing a Home growing CART Cell, and Philadelphia like leukemia in pediatric diagnosis and management.
Session I:
Pediatric Hematology- II
Session Covers Arterial Stroke in neonatal and young children, CART Cell in pediatric malignancy, and indication of thrombophilia workup in children and approach for patient with thrombophilia predisposition
Session II:
Transfusion
Session Covers Hemovigilance and blood safety, implementation of pathogen inactivation and blood safety, and patient blood management
Session III:
Lymphoproliferative & Plasma Cell Myeloma Disorders
A debate session discussing BV-based vs. Nivo-based therapy in untreated cHL, followed by updates on newly diagnosed myeloma. The session will also include a debate on CAR T-cell vs. bispecific antibodies therapy for refractory/relapsed DLBCL, and conclude with a tumor-based case discussion on HL, DLBCL, and PCM.
Session IV:
Hematopathology Session
Session Covers Challenges in T-Cell and NK cell lymphoma diagnosis, AML MRD flow vs molecular, and digital pathology and AI in Hematology diagnosis
Session V:
Acute Leukaemia Session- I
Session Covers incorporation of Gemtuzumab in the upfront management of AML , updates in upfront management of FLT3 positive AML, and Novel preparative regimens in allogeneic bone marrow transplant.
Session V:
Acute Leukaemia Session- II
Session covers value of NGS as MRD tool in AML, Impact of oncological therapy in clonal haematopoiesis and risk of tMN, and maintenance therapy for Acute Leukaemia post HSCT
Oral Abstract Sessions
CME Accreditation
Instructions for Claiming CME Certificates:
- Post the event, registered attendees will receive an online evaluation survey to their registered email address.
- Once the survey is completed, you will automatically receive the CME Certificate by email.
- Please ensure that the email address provided at the time of registration is accurate.
Disclosure and Resolution of Personal Conflicts of Interest
This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support.
Session Attendance Scanning :
- Attendance to the sessions will be monitored through scanning of the barcode on your conference badge at the entrance of the session hall.
- CME credits will be awarded in accordance with session attendance.
